- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07950605
Personalized Gait Retraining to Support Knee Health in Older Adults (BiofeedbackRCT)
A Real-time Biofeedback Intervention for Improving Tibiofemoral Cartilage Quality in Older Adults
Participants are randomized into two groups: gait retraining and habitual walking. In the gait retraining group, an intervention consisting of 10 training sessions on a treadmill aims to reduce medial tibiofemoral joint loading during walking. Real-time visual biofeedback on a knee joint loading metric is provided during some of the training sessions to facilitate learning. The habitual walking group participates in an equal number of training sessions where they perform their habitual walking and do not try to change their walking technique. Changes in knee joint cartilage properties are assessed at 5 months.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
In this randomized controlled intervention study, participants are randomized into two groups: gait retraining and habitual walking. At baseline and five months later, participants' gait mechanics and knee joint cartilage structure and quality are assessed, and blood and urine samples and questionnaire data are collected. In addition, knee joint radiographic status is assessed at baseline. Physical activity is monitored using a thigh-worn accelerometer throughout the study.
The intervention consisting of 10 training sessions on a treadmill aims to reduce medial tibiofemoral joint loading during walking. During the first session, participants try different kinematics-based gait modifications to personalize the intervention. The modifications that reduce estimated medial tibiofemoral knee joint loading the most are selected and utilized during the following sessions. The gait retraining aims at establishing a gait pattern for each individual that reduces medial tibiofemoral joint loading while also being such that the person can utilize it in their daily living. To support learning and fine-tuning the gait pattern, real-time feedback on knee joint moments is provided during part of the training sessions. The habitual walking group participates in an equal number of training sessions where they perform their habitual walking and do not try to change their walking technique. Eight of the training sessions are conducted within four weeks, while the two remaining sessions (so-called boosters) are conducted during the following four months with the aim of supporting maintenance of the learned gait pattern.
Pre-planned additional follow-ups are planned for 12 and 24 months from baseline. Knee MRI would be conducted at these follow-up points, with implementation depending on funding.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Lauri Stenroth, PhD
- Numéro de téléphone: +358505649096
- E-mail: lauri.stenroth@uef.fi
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Age above 65 or below 75 years (in full years)
- Access to a smartphone or tablet with an Android or iOS operating system
Exclusion Criteria:
- Unable to walk for 30 minutes without stopping and without an assistive device
- Body mass index <18 or >30 kg/m2
- Pain during walking
- Diagnosed with knee osteoarthritis
- Moderate (KL Grade 3) or severe (KL Grade 4) radiographical tibiofemoral osteoarthritis based on Kellgren-Lawrence (KL) Classification of Osteoarthritis
- Diagnosed with neurological disease
- Surgery of the knee joint
- Surgery or injury to the lower limbs causing pain or affecting mobility
- Current musculoskeletal injury causing pain or affecting mobility
- Contraindication for magnetic resonance imaging
- Contraindication for walking-based exercise training (e.g., cardiovascular symptoms that increase with exercise or recommendation from a medical professional to avoid moderate exercise)
- Any other condition that, in the opinion of the investigator, makes a potential participant unfit for participation or conditions that put a potential participant at risk by participation
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Gait retraining
The arm receives personalized gait retraining via treadmill walking and real-time feedback. |
Personalized gait retraining using small kinematic alterations guided by real-time feedback of knee joint loading. The training is perfomed on a treadmill. |
|
Autre: Habitual walking
The arm receives equal amount of treadmill walking without feedback or instruction to alter the gait. |
Participants receive equal amount of treadmill walking as the ones receiving gait retraining intervention. This intervention serves as the comparator for the gait retraining intervention. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Medial tibiofemoral T1ρ relaxation time
Délai: Baseline and 5 months
|
T1ρ relaxation time map of tibiofemoral cartilage from the medial compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Medial tibiofemoral T2 relaxation time
Délai: Baseline and 5 months
|
T2 relaxation time map of tibiofemoral cartilage from the medial compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
|
Lateral tibiofemoral T1ρ relaxation time
Délai: Baseline and 5 months
|
T1ρ relaxation time map of tibiofemoral cartilage from the lateral compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
|
Lateral tibiofemoral T2 relaxation time
Délai: Baseline and 5 months
|
T2 relaxation time map of tibiofemoral cartilage from the lateral compartment of the knee joint assessed using 3T MRI |
Baseline and 5 months
|
|
Tibiofemoral loading during walking
Délai: Baseline and 5 months
|
Tibiofemoral loading during walking assessed using musculoskeletal simulation |
Baseline and 5 months
|
|
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Délai: Baseline and 5 months
|
The score range is from 0 to 100. 0 represents extreme problems / worst possible knee symptoms. 100 represents no problems / perfect knee health. |
Baseline and 5 months
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
High-sensitivity C-reactive protein (hs-CRP)
Délai: Baseline and 5 months
|
hs-CRP (mg/L) is measured from blood samples using a particle-enhanced immunoturbidimetric assay as a marker of systemic inflammation. |
Baseline and 5 months
|
|
Glycated hemoglobin (HbA1c)
Délai: Baseline and 5 months
|
HbA1c (mmol/mol) is measured from blood samples using turbidimetric inhibition immunoassay as a marker of long-term blood glucose control. |
Baseline and 5 months
|
|
Knee cartilage recovery rate after loading assessed from magnetic resonance images
Délai: Baseline and 5 months
|
The knee joint is loaded with 20 minutes of standing and followed by repeated magnetic resonance imaging. Cartilage is segmented from the images, and the temporal recovery of the cartilage thickness in the medial tibiofemoral joint is quantified. The unit is mm/min. |
Baseline and 5 months
|
|
Proteomic analysis of serum samples
Délai: Baseline and 5 months
|
Liquid chromatography-mass spectrometry is used to run non-targeted peptide analysis of serum proteins. This is a pre-planned exploratory analysis that identifies hundreds of proteins and their concentration in the sample. |
Baseline and 5 months
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Lauri Stenroth, PhD, University of Eastern Finland
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 125/2025
- 363854 (Autre subvention/numéro de financement: Research Council of Finland)
- FIMEA/2025/007528-5 (Autre identifiant: Finnish Medicines Agency)
- 125/2025 (Autre identifiant: The Regional Medical Research Ethics Committee of Eastern Finland Collaborative Area)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
IPD used in the publications is planned to be shared.
Délai de partage IPD
At the time of publication with no end date.
Critères d'accès au partage IPD
Open access to the IPD and supporting information to be used in scientific research. If possible, the data is made available at the time of publishing the results with link to the data repository at the publication.
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- SÈVE
- CIF
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .